Showing 61 - 80 results of 133,096 for search '(( a d decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.42s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…Six microRNAs (miR-155, miR-454, miR-582-5p, let-7f-1*, miR-181d, and miR-500) had >1.2-fold increase in cirrhotic livers and also had significant negative correlation with hepatic CYP3A activity (range of r = -0.44 to -0.52, P <0.05). …”
  5. 65

    Rdh10a deficient embryos have decreased expression of RA signaling responsive genes. by Enrico D’Aniello (798447)

    Published 2015
    “…<p>(A-F) ISH for <i>cyp26a1</i>, <i>hoxb5b</i>, <i>and dhrs3a</i> expression in control sibling and Rdh10a deficient embryos. …”
  6. 66

    Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

    Published 2019
    “…<p>(A-D) Double staining of untreated 5xFAD mice brain sections with the 4g8 and SMI31 antibodies revealed that the areas with higher incidence of DNs display the greater total Aβ halo around the plaques (AmyloGlo+). …”
  7. 67

    Decreased reactive gliosis following ES delivered 5d post-demyelination. by Nikki A. McLean (643606)

    Published 2014
    “…Note: ES resulted in a significant decrease in the GFAP IF signal detected at 12d post-LPC (7 days post-ES; N) relative to 12d LPC only (M). …”
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  13. 73
  14. 74
  15. 75

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…Following P binder discontinuation, the long interdialytic interval mean ± SE serum P numerically increased from 5.8 ± 0.4 to 7.0 ± 0.5 mg/dl (p = 0.06). On patiromer, P decreased from 7.0 ± 0.5 to 6.2 ± 0.5 mg/dl (p = 0.04). …”
  16. 76
  17. 77
  18. 78
  19. 79

    Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner. by Silvia Siteni (10344070)

    Published 2024
    “…(C, D) Furthermore, metformin significantly decreases the expression of cleaved PARP, compared to the irradiated control. …”
  20. 80